Valentina Ciaravino

Valentina Ciaravino

Auto-generated profile, based on publicly available information

Valentina Ciaravino

Morgagni-Pierantoni Hospital, Forli, Italy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2019 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
VCValentina Ciaravino
Valentina Ciaravino
Mirko D'OnofrioMirko D'Onofrio
Mirko D'Onofrio

29 October 2025 in La radiologia medica
Verified
Journal Article
Open access
PDF file
Matteo RenzulliMatteo Renzulli
Matteo Renzulli
ACAlessandro Cucchetti
Alessandro Cucchetti
VZValentina Zucchini
Valentina Zucchini
VCValentina Ciaravino
Valentina Ciaravino
CBCecilia Binda
Cecilia Binda
EGEmanuela Giampalma
Emanuela Giampalma
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies, with limited therapeutic options and poor prognosis. Dynamic contrast-enhanced imaging provides valuable non-invasive information on tumor biology, and rim enhancement (RE) on computed tomography (CT) or magnetic resonance imaging (MRI) has emerged as a potential biomarker of aggressive disease. To clarify its clinical significance, a systematic review and meta-analysis of studies published up to May 31st, 2025, in Medline, Scopus, Web of Science, and the Cochrane Library was conducted. Twelve studies (10 retrospective, 2 prospective) including 2207 patients were analyzed. The pooled prevalence of RE was 36.3%, with a good inter-observer agreement ( κ = 0.808). RE was consistently associated with reduced resectability (odds ratio [OR] 3.35, 95% confidence interval [CI] 2.19–5.12, p < 0.001), poorer histological differentiation (OR 4.23, 95% CI 1.05–17.07, p = 0.043), and increased frequency of SMAD4 (OR 1.78, 95% CI 1.22–2.60, p = 0.003) and KRAS mutations (OR 2.55, 95% CI 1.37–4.75, p = 0.003). Patients with RE also experienced shorter progression-free, disease-free, and overall survival after both surgical and non-surgical treatments (all p < 0.001). These findings indicate that RE is a reproducible imaging marker of aggressive tumor biology in PDAC, reflecting unfavorable pathological and molecular features and serving as a predictor of resectability and survival.

1 December 2016
Verified
Book Chapter
Closed access
PDF file
Emilio QuaiaEmilio Quaia
Emilio Quaia
ASAnita Spezzacatene
Anita Spezzacatene
IZIrene Zorzenon
Irene Zorzenon
VCValentina Ciaravino
Valentina Ciaravino
ASAlessandri Sarno
Alessandri Sarno
Mirko D'OnofrioMirko D'Onofrio
Mirko D'Onofrio